RxDoctor Payments Data

Bradley Raphael, MD

Sports Medicine · Syracuse, NYNPI 1295992303

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 70.9% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $26,464, more than ten times the $332 reported in 2019. Among sports medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$70,186in general payments, 2019–2025

Across 88 payments — averaging $797.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$50K
  • Ziehm-orthoscan, Inc.$12K
  • Baxter Healthcare$5K
  • Prodigy Surgical Distribution, Inc.$2K
  • Arthrex$2K
  • Miach Orthopaedics, Inc.$538
  • plus $541 from 8 others
$146,633in research payments, 2019–2025

Across 27 payments — averaging $5430.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$147K

What the payments were for

  • Consulting fees$19,33828%
  • Speaking & faculty fees$41,84060%
  • Travel & lodging$3,6045%
  • Food & beverage$3,0044%
  • Education$2,4003%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,186 in reported general payments places this provider in the 90th percentile of 403 sports medicine providers in New York.

See all sports medicine providers in New York

Medicare billing

Part B allowed, 2024
$112,969
Medicare patients
348
Services billed
6,297

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam404$883
Cyclobenzaprine Hcl184$785
Methylprednisolone102$547
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen41$255
Cephalexin34$162
Diclofenac Sodium20$129

Paid to pharmacies, not to this prescriber.

Other sports medicine in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →